MedTrace Logo

Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary Study

NCT00769158 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2012-02-07

No results posted yet for this study

Summary

We propose to conduct an inpatient pilot study to test the safety and potential efficacy of topiramate and naltrexone in combination for the treatment of alcoholism.

Conditions

  • Alcoholism

Interventions

DRUG

Topiramate and Naltrexone

Topiramate 200 mg and Naltrexone 50 mg

OTHER

Placebo

Placebo Comparator

Sponsors & Collaborators

  • Bankole Johnson

    lead OTHER

Principal Investigators

  • Bankole Johnson, DSc,MD.PhD · University of Virginia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2010-10-31
Completion
2010-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00769158 on ClinicalTrials.gov